The Clorox Company (CLX) Fair Value 2026

CLX · Household & Personal Products ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.9 /10

32 fundamental signals · 11 models active

Value Trap Risk

SAFE (6/100)

Quick Summary — As of 2026-08-28, The Clorox Company (CLX) trades at $102.53, versus a $115.37 median fair value across its 11 active models — 12.5% above the current price. QOC: 7.9/10. Value Trap Risk: 6/100 (SAFE). 11/13 models active. Within that set, the Bayesian DCF component alone returns $115.37.

Key Facts

Ticker
CLX
Price
$102.53
Quality Score
7.9/10
Value Trap Risk
6/100
Models Active
11/13
Last Updated
Strength: First Chicago suggests +52.1% upside with 65% confidence
Risk: Limited model coverage (11/13) may reduce confidence

Is The Clorox Company (CLX) Undervalued or Overvalued in 2026?

According to CirclFi’s 11-model valuation engine, The Clorox Company (CLX) appears undervalued as of : the median of 11 independent fair value estimates is $115.37, 12.5% above the current price of $102.53. Estimates range from $34.51 to $176.24. CLX scores 7.9/10 on fundamental quality and 6/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. CLX’s +12.5% gap is narrower than that market norm, and the Household & Personal Products sector median is -7.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy The Clorox Company Stock in 2026? →

What Fair Value Does Each Model Give CLX?

11 Intrinsic Value Models vs. Current Price ($102.53)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $115.37 +12.5%
Intrinsic · High Conviction
 $46.72 -54.4%
Ensemble · Medium Conviction
 $108.40 +5.7%
Scenario · High Conviction
 $155.90 +52.1%
Unlock the Full Matrix

Access 7 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 11 Models →

Cancel anytime · No contracts · Instant access

What Is CLX's Fair Value Range?

Spread across 11 independent models · $34.51 to $176.24

CirclFi's 11 active models place The Clorox Company (CLX) between $34.51 and $176.24 per share, a spread of 123% of the median. The median of that range — $115.37 — is the fair value CirclFi publishes for CLX, against a current price of $102.53.

Low · EROICHigh · Regime Cross
$34.51median $115.37$176.24
Where the range comes from
Most bearish modelEROIC Spread$34.51
Most bullish modelRegime Cross-Sectional$176.24
Model agreement8 bullish · 3 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for CLX. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on CLX, not a CirclFi price target. How each model works →

What Is The Clorox Company (CLX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on The Clorox Company at $102.53. With an estimated intrinsic value of $115.37 and 8 of 11 models pointing higher, the median implied return is +12.5%. The most optimistic model, Regime Cross, places fair value at $176.24 (+71.9%), while EROIC — the most conservative — estimates $34.51 (-66.3%). This +138.2% gap reflects genuine analytical uncertainty about The Clorox Company's intrinsic worth. Among models with highest confidence, Bayesian DCF, EPV, EROIC lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About CLX?

11 of 13 models are currently active for CLX. Of these, 8 models suggest upside while 3 models suggest overvaluation. Taken together, their median fair value for CLX is $115.37 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $115.37 on its own, implying +12.5% upside from the current price. See which stocks rank higher →

How Does CLX Rank in Household & Personal Products?

Among 35 Household & Personal Products stocks, CLX ranks #9 by Quality of Company score. CirclFi's QOC score of 7.9/10 evaluates 32 fundamental signals. A score of 7.9 indicates above-average quality.

Within the Household & Personal Products space, The Clorox Company competes in an environment where store traffic trends often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is CLX a Value Trap?

CirclFi's Value Trap algorithm assigns CLX a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

11 of 13 models are active for The Clorox Company. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, The Clorox Company's fundamental quality profile registers 7.9/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +138.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CLX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CLX's 11 active models, average confidence is 57%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy The Clorox Company Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Household & Personal Products Stocks Should You Also Analyze?

11 related Household & Personal Products stocks with 13-model coverage

KMBKimberly-Clark CorporationQOC 8.0NUSNu Skin Enterprises, Inc.QOC 7.7UGUnited-Guardian, Inc.QOC 8.1SPBSpectrum Brands Holdings, Inc.QOC 7.7ELFe.l.f. Beauty, Inc.QOC 8.1ULUnilever PLCQOC 7.6YSGYatsen Holding LimitedQOC 6.8SKINSkinHealth Systems Inc.QOC 6.0TANHTantech Holdings LtdQOC 1.4IPARInterparfums, Inc.QOC 9.3PGThe Procter & Gamble CompanyQOC 8.8

Read investment analysis: KMB · NUS · UG · SPB · ELF · UL · YSG · SKIN · TANH · IPAR · PG

Which Other Stocks Have a Similar Quality Score to CLX?

7 companies across all industries closest to CLX’s Quality of Company score of 7.9/10.

GSBCGreat Southern Bancorp, Inc.QOC 7.9IMXIInternational Money Express, Inc.QOC 7.9MDPediatrix Medical Group, Inc.QOC 7.9HPQHP Inc.QOC 7.9LHXL3Harris Technologies, Inc.QOC 7.9AUBAtlantic Union Bankshares CorporationQOC 7.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: GSBC · IMXI · MD · HPQ · LHX · AUB · NVDA

What Else Do Investors Ask About The Clorox Company’s Valuation?

What is The Clorox Company's intrinsic value in 2026?

CirclFi puts The Clorox Company (CLX)'s intrinsic value at $115.37 — the median of 11 independent model estimates as of 2026-08-28, ranging from $34.51 to $176.24. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $115.37 on its own. The Quality of Company score is 7.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CLX overvalued or undervalued right now?

At $102.53, 8 of 11 active models suggest CLX may be undervalued, while 3 indicate potential overvaluation. The median of all 11 fair value estimates is $115.37, 12.5% above the current price of $102.53 — a consensus view that CLX is undervalued. The assessment depends on which methodology best fits The Clorox Company's business model in Household & Personal Products.

What does a Quality of Company score of 7.9 mean for CLX?

The Clorox Company's QOC of 7.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on CLX?

CirclFi analyzes CLX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 11 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on CLX?

Of the 11 models currently active on CLX, Regime Cross-Sectional is the most bullish at $176.24 per share, and EROIC Spread is the most bearish at $34.51. CirclFi's published fair value for CLX is the median of that range, $115.37, not either extreme. The gap between the two ends equals 123% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is CLX a value trap in 2026?

The Clorox Company's Value Trap score is 6/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 11-model valuation engine, The Clorox Company (CLX) has a median fair value of $115.37 — 12.5% above the current price of $102.53 — as of 2026-08-28.” Source: circlfi.com/stock/CLX/ · Methodology
Primary sources for this CLX valuation
  • Financial statements: The Clorox Company 10-K and 10-Q filings on SEC EDGAR (CIK 0000021076) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CLX as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 11 mathematical frameworks give you clarity on CLX.

Unlock All 11 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

7 models hidden for CLX Unlock All 11 — $39/mo